Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Cash from Financing Activities (2016 - 2025)

United Health Products (UEEC) has disclosed Cash from Financing Activities for 15 consecutive years, with $193308.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 43.94% to $193308.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $789846.0, a 49.35% decrease, with the full-year FY2024 number at $1.3 million, down 44.51% from a year prior.
  • Cash from Financing Activities was $193308.0 for Q3 2025 at United Health Products, up from $180000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $597881.0 in Q4 2023 to a low of $92377.0 in Q3 2022.
  • A 5-year average of $305145.8 and a median of $243087.0 in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: crashed 72.01% in 2022, then skyrocketed 490.2% in 2023.
  • United Health Products' Cash from Financing Activities stood at $238802.0 in 2021, then tumbled by 43.42% to $135115.0 in 2022, then soared by 342.5% to $597881.0 in 2023, then tumbled by 48.73% to $306538.0 in 2024, then tumbled by 36.94% to $193308.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Cash from Financing Activities are $193308.0 (Q3 2025), $180000.0 (Q2 2025), and $110000.0 (Q1 2025).